Business Description
Tharimmune Inc
NAICS : 325412
SIC : 2834
ISIN : US4327052001
Description
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 19.53 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -13.8 | |||||
| 3-Year EPS without NRI Growth Rate | -14.7 | |||||
| 3-Year FCF Growth Rate | -32.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.5 | |||||
| 9-Day RSI | 38.28 | |||||
| 14-Day RSI | 40.13 | |||||
| 6-1 Month Momentum % | -90.41 | |||||
| 12-1 Month Momentum % | -97.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.03 | |||||
| Quick Ratio | 6.03 | |||||
| Cash Ratio | 6.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -196.8 | |||||
| Shareholder Yield % | -287.41 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -205.25 | |||||
| ROA % | -154.68 | |||||
| ROIC % | -2945.48 | |||||
| ROC (Joel Greenblatt) % | -4844.79 | |||||
| ROCE % | -204.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.47 | |||||
| Price-to-Tangible-Book | 0.47 | |||||
| EV-to-EBIT | -0.13 | |||||
| EV-to-EBITDA | -0.13 | |||||
| EV-to-FCF | -0.17 | |||||
| Price-to-Net-Current-Asset-Value | 0.47 | |||||
| Price-to-Net-Cash | 0.47 | |||||
| Earnings Yield (Greenblatt) % | -769.23 | |||||
| FCF Yield % | -167.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:THAR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tharimmune Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -12.711 | ||
| Beta | 0 | ||
| Volatility % | 83 | ||
| 14-Day RSI | 40.13 | ||
| 14-Day ATR ($) | 0.026275 | ||
| 20-Day SMA ($) | 0.40295 | ||
| 12-1 Month Momentum % | -97.58 | ||
| 52-Week Range ($) | 0.3439 - 12.475 | ||
| Shares Outstanding (Mil) | 11.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tharimmune Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tharimmune Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tharimmune Inc Frequently Asked Questions
What is Tharimmune Inc(THAR)'s stock price today?
The current price of THAR is $0.37. The 52 week high of THAR is $12.48 and 52 week low is $0.34.
When is next earnings date of Tharimmune Inc(THAR)?
The next earnings date of Tharimmune Inc(THAR) is 2024-05-22 Est..
Does Tharimmune Inc(THAR) pay dividends? If so, how much?
Tharimmune Inc(THAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers